Cargando…

Can dexamethasone prevent the seizures induced by SARS-CoV-2 infection?

Detalles Bibliográficos
Autores principales:	Vizuete, Adriana Fernanda K., Gonçalves, Carlos-Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590631/ https://www.ncbi.nlm.nih.gov/pubmed/33137605 http://dx.doi.org/10.1016/j.msard.2020.102606

Ejemplares similares

Effects of dexamethasone on the Li-pilocarpine model of epilepsy: protection against hippocampal inflammation and astrogliosis
por: Vizuete, Adriana Fernanda K., et al.
Publicado: (2018)

SARS‑CoV‑2 and Seizure: An Insight Into the Pathophysiology
por: Ahadiat, Seyed Amir Abbas, et al.
Publicado: (2023)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Characteristics of febrile seizures with SARS-CoV-2 infection in the Omicron era
por: Kim, Jee Min, et al.
Publicado: (2023)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Acute Seizures Occurring in Association With SARS-CoV-2
por: Hwang, Sean T., et al.
Publicado: (2020)

Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis
por: Ferreto, Lirane Elize Defante, et al.
Publicado: (2021)

Seizures as the main presenting manifestation of acute SARS-CoV-2 infection in children()
por: Kurd, Mohammad, et al.
Publicado: (2021)

Seizures in Children with SARS-CoV-2 Infection: Epidemiological, Clinical and Neurophysiological Characterization
por: Pascarella, Antonia, et al.
Publicado: (2022)

Dexamethasone-induced withdrawal seizure
por: Mahar, Santwana, et al.
Publicado: (2015)

SARS-CoV-2 can infect human embryos
por: Montano, Mauricio, et al.
Publicado: (2022)

Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
por: Yoon, Jin Gu, et al.
Publicado: (2022)

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
por: Vohra, Manik, et al.
Publicado: (2021)

Effect of SARS-CoV-2 infection on seizure, anxiety and depression in 107 epilepsy patients
por: Zhou, Sichao, et al.
Publicado: (2023)

UV and violet light can Neutralize SARS-CoV-2 Infectivity
por: Biasin, Mara, et al.
Publicado: (2022)

SARS-CoV-2 can infect and propagate in human placenta explants
por: Fahmi, Amal, et al.
Publicado: (2021)

Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages
por: Wang, Zhenfeng, et al.
Publicado: (2022)

Dexamethasone/prednisone/rituximab: Prolonged SARS-CoV-2 infection and off-label use: case report
Publicado: (2022)

Prevention and Control Strategies for SARS-CoV-2 Infection
por: Srivastava, Nishant, et al.
Publicado: (2020)

Practical measures for SARS-CoV-2 infection prevention
por: Fujikawa, Tatsuya
Publicado: (2022)

Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone()
por: Feria, Lucia, et al.
Publicado: (2022)

SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
por: Diaz de la Fe, Amado, et al.
Publicado: (2021)

Seizure and neuropsychiatric compromise as onset of SARS-CoV-2 associated encephalitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
por: Manzo, Ciro, et al.
Publicado: (2021)

Organizing pneumonia associated with SARS-CoV-2 infection
por: Cortés Colorado, Julián Mauricio, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Favipiravir use for SARS CoV-2 infection
por: Boretti, Alberto
Publicado: (2020)

Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?
por: Juric, Ivana, et al.
Publicado: (2021)

Is SARS-CoV-2 Infection a Risk for Potentiation of Epileptic Seizures in Children With Pre-existing Epilepsy?
por: Brisca, Giacomo, et al.
Publicado: (2021)

Frequency of new seizures after SARS-CoV-2 infections may depend on the length of follow-up
por: Finsterer, Josef
Publicado: (2023)

Does SARS-CoV-2 Cause Seizures and Epilepsy in COVID-19 via Inflammation or by Direct Infection?
por: Vossler, David G.
Publicado: (2023)

Attacking the defence: SARS-CoV-2 can infect immune cells
por: Borsa, Mariana, et al.
Publicado: (2020)

Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
por: Krey, Lea, et al.
Publicado: (2021)

Bees can be trained to identify SARS-CoV-2 infected samples
por: Kontos, Evangelos, et al.
Publicado: (2022)

Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
por: Swadling, Leo, et al.
Publicado: (2023)

Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis
por: Xiao, Yong, et al.
Publicado: (2020)

Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
por: Conway, Susan R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i9031ffpfi6mgqukapscnv3arb